The Midline Catheter Market is gaining significant opportunities from the growing need for vascular access in oncology treatment. Cancer patients frequently require intravenous chemotherapy, supportive medications, fluids, and other treatments, creating demand for dependable catheter technologies across hospitals and other healthcare facilities.

According to Market Research Future, the global Midline Catheter Market was valued at USD 1.259 Billion in 2024 and is forecast to reach USD 2.824 Billion by 2035, growing at a CAGR of 7.62% during 2025–2035. The market is expected to reach USD 1.355 Billion in 2025.

Oncology accounted for approximately 44% of the market by application, making it the largest application segment. The increasing global cancer burden and expanding requirements for intravenous treatment are important factors supporting this position.

Midline catheters can be valuable in appropriate clinical situations where patients require intermediate-duration vascular access. Their use can help healthcare professionals administer medications and fluids while supporting patient mobility and treatment convenience.

The increasing focus on patient-centered cancer care is also contributing to demand. Healthcare providers are increasingly looking for treatment approaches that combine clinical effectiveness with patient comfort. Catheter technologies designed around flexibility, ease of use, and safety can support these objectives.

Hospitals represent the largest end-use segment, accounting for approximately 67% of market demand. Oncology services are heavily concentrated in hospitals and specialized treatment centers, where intravenous therapies are frequently administered.

Material innovation is another factor supporting market development. Polyurethane leads the material category with approximately 46% share due to properties such as flexibility and biocompatibility. Continued research into catheter materials could further improve device performance and patient experience.

North America maintains a leading position, accounting for more than 47% of global revenue in 2024. Advanced oncology infrastructure, healthcare spending, and widespread adoption of vascular access technologies support regional growth.

With cancer treatment requirements continuing to evolve and healthcare providers emphasizing safer and more efficient intravenous therapy, oncology is expected to remain a major contributor to the future growth of the Midline Catheter Market.